Digital Yuan Push: China’s central bank is expanding e-CNY use at home and abroad, with incentives for banks and directives for payments, trade, and even fiscal spending—aimed at reducing reliance on the dollar. Child Health & Care Access: China issued new guidance to better track distressed migrant and left-behind children, requiring cross-checking across education, health, and public security systems to ensure equal access. Public Health for Youth: China’s community-based smoking cessation push is bringing quitting support closer to home, while youth athletics events are growing nationwide to boost grassroots participation. Biotech Deal Watch: Pfizer and Innovent Biologics signed a global oncology agreement worth up to $10.5B to develop 12 cancer programs, underscoring how fast China’s drug pipeline is attracting global capital. Infectious Disease Update: Wockhardt’s ZAYNICH (cefepime + zidebactam) won US FDA approval for complicated UTIs, with shares jumping on the news. Cancer Immunotherapy Signals: ASCO 2026 data highlights multiple China-linked advances, including Oricell’s GPC3 CAR-T Ori-C101 and other next-gen lung cancer and CAR-T readouts. Health Services for Vulnerable Kids: A China Focus report shows social workers connecting families of children with autism to home-based rehabilitation, improving access where local systems were hard to navigate. Animal Welfare: Laos rescued 27 moon bears from an illegal bile farm tied to a Chinese operator, moving them to a sanctuary. Safety & Risk: A blast near the Chinese border in Myanmar killed 45+ people, with many injured—another reminder of health risks tied to hazardous materials and conflict zones.